Case 1:08-cv-00052-GMS-LPS
Document 87
Filed 05/16/2008
Page 1 of 3
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE __________________________________________ FOREST LABORATORIES, INC., ) FOREST LABORATORIES HOLDINGS, LTD., ) MERZ PHARMA GMBH & CO. KGAA, and ) MERZ PHARMACEUTICALS GMBH ) ) Plaintiffs ) v. ) ) DR. REDDY'S LABORATORIES, INC., DR. ) REDDY'S LABORATORIES LIMITED, ) C.A. No. 08-52 (GMS)(LPS) GENPHARM INC., GENPHARM, L.P., ) INTERPHARM HOLDINGS, INC., ) INTERPHARM, INC., MYLAN ) PHARMACETICALS INC., SUN INDIA ) PHARMACEUTICAL INDUSTRIES LIMITED ) (a/k/a SUN PHARMACEUTICAL INDUSTRIES ) LTD.), SYNTHON HOLDING B.V., SYNTHON ) B.V., SYNTHON LABORATORIES, INC., and ) SYNTHON PHARMACEUTICALS, INC. ) ) Defendants. ) __________________________________________) STIPULATION AND ORDER OF DISMISSAL Plaintiffs Forest Laboratories, Inc., Forest Laboratories Holdings, Ltd., Merz Pharma GmbH & Co. KGaA, and Merz Pharmaceuticals GmbH (collectively, "Plaintiffs") and Synthon Holding B.V., Synthon B.V., Synthon Laboratories, Inc. and Synthon Pharmaceuticals, Inc. (collectively, "the Synthon Entities") hereby stipulate as follows: WHEREAS Synthon Laboratories Inc. filed with the United States Food and Drug Administration ("FDA") its Abbreviated New Drug Application ("ANDA") No. 90-047, which sought approval for the manufacture, use and sale of its generic memantine hydrochloride tablets;
Case 1:08-cv-00052-GMS-LPS
Document 87
Filed 05/16/2008
Page 2 of 3
WHEREAS ANDA No. 90-047 contained a certification pursuant to § 505(j)(2)(A)(vii)(IV) that the claims of U.S. Patent No. 5,061,703 ("the `703 patent") were invalid, unenforceable, and/or not infringed by Synthon Laboratories Inc.'s proposed generic memantine hydrochloride tablets; WHEREAS Plaintiffs brought suit in this Court against the Synthon Entities on February 15, 2008 (D.I. 31), charging the Synthon Entities with infringement of the `703 Patent, pursuant to 35 U.S.C. § 271(e)(2)(A); and WHEREAS, for purposes of this action and this Stipulation and Order of Dismissal, the Synthon Entities do not contest personal jurisdiction in this Court. Now, THEREFORE, it is hereby Stipulated and Agreed that: (1) Synthon Laboratories, Inc. represents that it has withdrawn ANDA No.
90-047, and the Synthon Entities represent that they do not have a pending ANDA for memantine hydrochloride tablets. (2) The Synthon Entities represent that they have not engaged in any
manufacture, use, sale, offer for sale or importation of the products described in ANDA No. 90-047 in this country for commercial, non-regulatory purposes. (3) Because the Synthon Entities no longer have a pending ANDA seeking
approval of generic memantine hydrochloride tablets, this Court no longer has subject matter jurisdiction over this matter. (4) (5) The parties consent to the dismissal of this action without prejudice. This Court retains jurisdiction over the parties for purposes of enforcing
this Stipulation and Order of Dismissal. (6) Each party shall bear its own costs.
2
Case 1:08-cv-00052-GMS-LPS
Document 87
Filed 05/16/2008
Page 3 of 3
MORRIS, NICHOLS, ARSHT & TUNNELL LLP
PRICKETT, JONES & ELLIOT, P.A.
/s/ Jack B. Blumenfeld
__________________________________ Jack B. Blumenfeld (#1014) Maryellen Noreika (#3208) 1201 North Market Street P.O. Box 1347 Wilmington, DE 19899 (302) 658-9200 [email protected] [email protected] Of Counsel: John Desmarais Gerald J. Flattmann, Jr. Melanie R. Rupert KIRKLAND & ELLIS LLP Citigroup Center 153 East 53rd Street New York, NY 10022 (202) 783-6040 F. Dominic Cerrito Daniel L. Malone Eric C. Stops JONES DAY 222 East 41st Street New York, NY 10017 (212) 326-3939 Attorneys for Plaintiffs Forest Laboratories, Inc. Forest Laboratories Holdings, Ltd., Merz Pharma GmbH & Co. KGAA and Merz Pharmaceuticals GmbH SO ORDERED:
/s/ Melissa N. Donimirski
Elizabeth M. McGeever (#2057) Melissa N. Donimirski (#4701) 1310 King Street P.O. Box 1328 Wilmington, DE 19899 (302) 888-6500 [email protected] [email protected] Of Counsel: Joseph A. Hynds E. Anthony Figg Lisa N. Phillips ROTHWELL, FIGG, ERNST & MANBECK, P.C. 1425 K Street, N.W. Suite 800 Washington, D.C. 20005 (212) 446-4800 Attorneys for Defendants Synthon Holding B.V., Synthon B.V., Synthon Laboratories, Inc. and Synthon Pharmaceuticals, Inc.
Dated: ____________________________
____________________________________ Hon. Gregory M. Sleet United States District Judge
3